Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1225 of 1467 entries
View as:

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT00263042 Org: User:
Start: 12/31/05 End: 04/30/09 Due: 04/30/10

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Phase: N/A Priority: Normal
NCT ID: NCT01147250 Org: User:
Start: 06/30/10 End: 02/28/15 Due: 02/28/16

Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.

Phase: N/A Priority: Normal
NCT ID: NCT00785590 Org: User:
Start: 08/31/08 End: 09/30/08 Due: 09/30/09

Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

Phase: N/A Priority: Normal
NCT ID: NCT00971581 Org: User:
Start: 08/31/09 End: 05/31/10 Due: 05/31/11

SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00796731 Org: User:
Start: 10/31/08 End: 06/30/12 Due: 06/30/13

Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT04075513 Org: User:
Start: 10/09/19 End: 09/16/21 Due: 09/16/22

A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines

Phase: N/A Priority: Normal
NCT ID: NCT01064141 Org: User:
Start: 01/31/10 End: 11/30/12 Due: 11/30/13

Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology

Phase: N/A Priority: Normal
NCT ID: NCT00629720 Org: User:
Start: 07/31/06 End: 02/28/07 Due: 02/28/08

A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00611507 Org: User:
Start: 11/30/02 End: 04/30/04 Due: 04/30/05

A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT00728091 Org: User:
Start: 07/31/08 End: 12/31/08 Due: 12/31/09

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06975722 Org: User:
Start: 06/03/25 End: 10/17/29 Due: 10/17/30

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

Phase: N/A Priority: Normal
NCT ID: NCT00325390 Org: User:
Start: 07/31/04 End: - Due: -

An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

Phase: N/A Priority: Normal
NCT ID: NCT06686628 Org: User:
Start: 11/20/24 End: 04/03/26 Due: 04/03/27

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Phase: N/A Priority: Normal
NCT ID: NCT06059456 Org: User:
Start: 10/02/23 End: 12/15/23 Due: 12/15/24

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT00133731 Org: User:
Start: 09/30/04 End: 10/31/05 Due: 10/31/06

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Phase: N/A Priority: Normal
NCT ID: NCT00062803 Org: User:
Start: 06/30/03 End: 10/31/05 Due: 10/31/06

A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Phase: N/A Priority: Normal
NCT ID: NCT00514917 Org: User:
Start: 07/31/07 End: 09/30/12 Due: 09/30/13

Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

Phase: N/A Priority: Normal
NCT ID: NCT00368797 Org: User:
Start: 03/31/02 End: 04/30/05 Due: 04/30/06

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01499095 Org: User:
Start: 12/31/11 End: 11/30/13 Due: 11/30/14

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00721760 Org: User:
Start: 07/31/08 End: 10/31/09 Due: 10/31/10

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus

Phase: N/A Priority: Normal
NCT ID: NCT00565162 Org: User:
Start: 11/30/03 End: 06/30/05 Due: 06/30/06

A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05607173 Org: User:
Start: 01/18/23 End: 05/03/23 Due: 05/03/24

Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00741897 Org: User:
Start: 03/31/02 End: - Due: -

A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566

Phase: N/A Priority: Normal
NCT ID: NCT05844735 Org: User:
Start: 05/22/23 End: 10/23/23 Due: 10/23/24

Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00559455 Org: User:
Start: 09/30/07 End: 01/31/10 Due: 01/31/11